Background: Our aim was to determine the effect of single endometriomas ≤3 cm in diameter per se on ovarian reserve in intracytoplasmic sperm injection (ICSI) cycles. Methods: We enrolled 19 consecutive infertile patients (29 cycles) who had unilateral single endometriomas ≤3 cm in diameter and who underwent ICSI. Results: The mean age of the patients was 33.3 ± 4.9 years. The mean diameter of endometriomas was 21.8 ± 4.9 mm. Left- and right-sided endometriomas were 34.5 and 65.5%, respectively. The number of oocytes retrieved from ovaries with endometriomas and contralateral normal ovaries was comparable (5.9 ± 4.3 vs. 5.4 ± 3.8). Conclusion: Endometriomas ≤3 cm in diameter per se did not have a deleterious effect on ovarian reserve in ICSI cycles.

Giudice LC, Kao LC: Endometriosis. Lancet 2004;364:1789–1799.
Redwine DB: Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease. Fertil Steril 1999;72:310–315.
Vercellini P, Fedele L, Aimi G, De Giorgi O, Consonni D, Crosignani PG: Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis: the predictive value of the current classification system. Hum Reprod 2006;21:2679–2685.
Alborzi S, Momtahan M, Parsanezhad ME, Dehbashi S, Zolghadri J: A prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomas. Fertil Steril 2004;82:1633–1637.
Beretta P, Franchi M, Ghezzi F, Busacca M, Zupi E, Bolis P: Randomized clinical trial of two laparoscopic treatments of endometriomas: cystectomy versus drainage and coagulation. Fertil Steril 1998;70:1176–1180.
Falcone T, Lebovic DI: Clinical management of endometriosis. Obstet Gynecol 2011;118:691–705.
Esinler I, Bozdag G, Aybar F, Bayar U, Yarali H: Outcome of in vitro fertilization/intracytoplasmic sperm injection after laparoscopic cystectomy for endometriomas. Fertil Steril 2006;85:1730–1735.
Almog B, Sheizaf B, Shalom-Paz E, Shehata F, Al-Talib A, Tulandi T: Effects of excision of ovarian endometrioma on the antral follicle count and collected oocytes for in vitro fertilization. Fertil Steril 2010;94:2340–2342.
Duru NK, Dede M, Acikel CH, Keskin U, Fidan U, Baser I: Outcome of in vitro fertilization and ovarian response after endometrioma stripping at laparoscopy and laparotomy. J Reprod Med 2007;52:805–809.
Ercan CM, Duru NK, Karasahin KE, Coksuer H, Dede M, Baser I: Ultrasonographic evaluation and anti-müllerian hormone levels after laparoscopic stripping of unilateral endometriomas. Eur J Obstet Gynecol Reprod Bio 2011;158:280–284.
Ragni G, Somigliana E, Benedetti F, Paffoni A, Vegetti W, Restelli L, Crosignani PG: Damage to ovarian reserve associated with laparoscopic excision of endometriomas: a quantitative rather than a qualitative injury. Am J Obstet Gynecol 2005;193:1908–1914.
Kumbak B, Kahraman S, Karlikaya G, Lacin S, Guney A: In vitro fertilization in normoresponder patients with endometriomas: comparison with basal simple ovarian cysts. Gynecol Obstet Invest 2008;65:212–216.
Benaglia L, Somigliana E, Vercellini P, Abbiati A, Ragni G, Fedele L: Endometriotic ovarian cysts negatively affect the rate of spontaneous ovulation. Hum Reprod 2009;24:2183–2186.
Almog B, Shehata F, Sheizaf B, Tan SL, Tulandi T: Effects of ovarian endometrioma on the number of oocytes retrieved for in vitro fertilization. Fertil Steril 2011;95:525–527.
Alcazar JL, Laparte C, Jurado M, Lopez-Garcia G: The role of transvaginal ultrasonography combined with color velocity imaging and pulsed Doppler in the diagnosis of endometrioma. Fertil Steril 1997;67:487–491.
Barash A, Weissman A, Manor M, Milman D, Ben-Arie A, Shoham Z: Prospective evaluation of endometrial thickness as a predictor of pituitary down-regulation after gonadotropin-releasing hormone analogue administration in an in vitro fertilization program. Fertil Steril 1998;69:496–499.
Bukulmez O, Yarali H, Yucel A, Sari T, Gurgan T: Intracytoplasmic sperm injection versus in vitro fertilization for patients with a tubal factor as their sole cause of infertility: a prospective, randomized trial. Fertil Steril 2000;73:38–42.
Maneschi F, Marasa L, Incandela S, Mazzarese M, Zupi E: Ovarian cortex surrounding benign neoplasms: a histologic study. Am J Obstet Gynecol 1993;169:388–393.
Kitajima M, Defrere S, Dolmans MM, Colette S, Squifflet J, Van Langendonckt A, Donnez J: Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis. Fertil Steril 2011;96:685–691.
Zhang X, Li XH, Ma X, Wang ZH, Lu S, Guo YL: Redox-induced apoptosis of human oocytes in resting follicles in vitro. J Soc Gynecol Invest 2006;13:451–458.
Matsuzaki S, Schubert B: Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis. Fertil Steril 2010;93:2431–2432.
Somigliana E, Infantino M, Benedetti F, Arnoldi M, Calanna G, Ragni G: The presence of ovarian endometriomas is associated with a reduced responsiveness to gonadotropins. Fertil Steril 2006;86:192–196.
Benaglia L, Pasin R, Somigliana E, Vercellini P, Ragni G, Fedele L: Unoperated ovarian endometriomas and responsiveness to hyperstimulation. Hum Reprod 2011;26:1356–1361.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.